Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|February 1, 1989
Quinolone antimicrobial agents: mechanism of action and resistance developmentL E Bryan, J Bedard, S Wong, et al.The Journal of Antibiotics|April 17, 1998
Synthesis and antimicrobial evaluation of TAN-1057A/B analogsR M Williams, C Yuan, V J Lee, et al.Antimicrobial Agents and Chemotherapy|September 1, 1989
Contribution of permeability and sensitivity to inhibition of DNA synthesis in determining susceptibilities of Escherichia coli, Pseudomonas aeruginosa, and Alcaligenes faecalis to ciprofloxacinJ Bedard, S Chamberland, S Wong, et al.Journal of Dairy Science|August 9, 2024
Biofilm Dairy Foods Review: Effect of biofilm production on antimicrobial susceptibility of Staphylococcus aureus bovine mastitis strains from the most prevalent Canadian spa typesE Demontier, C Ster, S Chamberland, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 1, 1992
Antibiotic susceptibility profiles of 941 gram-negative bacteria isolated from septicemic patients throughout Canada. The Canadian Study GroupS Chamberland, J L'Ecuyer, C Lessard, et al.Antimicrobial Agents and Chemotherapy|May 1, 1989
Characterization of mechanisms of quinolone resistance in Pseudomonas aeruginosa strains isolated in vitro and in vivo during experimental endocarditisS Chamberland, A S Bayer, T Schollaardt, et al.The Journal of Antimicrobial Chemotherapy|June 1, 1990
Persistence of Pseudomonas aeruginosa during ciprofloxacin therapy of a cystic fibrosis patient: transient resistance to quinolones and protein F-deficiencyS Chamberland, F Malouin, H R Rabin, et al.Antimicrobial Agents and Chemotherapy|September 1, 1987
Mechanism of Pseudomonas aeruginosa persistence during treatment with broad-spectrum cephalosporins of lung infections in patients with cystic fibrosisA B Schryvers, J Ogunariwo, S Chamberland, et al.Antimicrobial Agents and Chemotherapy|May 29, 1999
Use of a genetic approach to evaluate the consequences of inhibition of efflux pumps in Pseudomonas aeruginosaO Lomovskaya, A Lee, K Hoshino, et al.Antimicrobial Agents and Chemotherapy|April 17, 2001
In vitro activities of RWJ-54428 (MC-02,479) against multiresistant gram-positive bacteriaS Chamberland, J Blais, M Hoang, et al.Pageof 3